(Q33852654)

29 July 2017

1 reference

title

A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia (English)

1 reference

29 July 2017

J Kildsgaard

1

1 reference

29 July 2017

E Zsigmond

series ordinal

2

1 reference

29 July 2017

L Chan

series ordinal

3

1 reference

29 July 2017

R A Wetsel

series ordinal

4

1 reference

29 July 2017

1 September 1999

1 reference

29 July 2017

1 reference

29 July 2017

36

1 reference

29 July 2017

869-876

1 reference

29 July 2017

13-14

1 reference

Molecular cloning and characterization of the human anaphylatoxin C3a receptor

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

The influence of oral lipid loads on acylation stimulating protein (ASP) in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Regulation of alternative pathway activation and C3a production by adipose cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Acylation stimulating protein and the adipocyte

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

The acylation stimulating protein pathway: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Differentiation-induced production of ASP in human adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Acylation stimulating protein (ASP), an adipocyte autocrine: new directions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Severely impaired adipsin expression in genetic and acquired obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Hyperapobetalipoproteinemia. Plasma lipoprotein responses to oral fat load.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Soluble proteins in the human atherosclerotic plaque. With spectral reference to immunoglobulins, C3-complement component, alpha 1-antitrypsin and alpha 2-macroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Acylation-stimulatory activity in hyperapobetalipoproteinemic fibroblasts: enhanced cholesterol esterification with another serum basic protein, BP II

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Elevated plasma C3 anaphylatoxin levels in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Association of serum C3 levels with the risk of myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

The value of complement activation products in the assessment of systemic lupus erythematosus flares

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Complement C3 deficiency: human, animal, and experimental models

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

The adipsin-acylation-stimulating protein pathway and microenvironmental metabolic regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

The adipocyte, fatty acid trapping, and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoB.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

The acylation-stimulating protein pathway and regulation of postprandial metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Adipose tissue glyceride synthesis in patients with hyperapobetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Processes in atherogenesis: complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Immunoglobulins and complement components in human aortic atherosclerotic intima

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Genetic deficiency of acylation stimulating protein (ASP(C3ades-Arg)) does not cause hyperapobetalipoproteinemia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Serum complement and familial combined hyperlipidemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900108-X

7 January 2021

10.1016/S0161-5890(99)00108-X

Identifiers

DOI

1 reference

29 July 2017

1 reference